Triazolo [1, 5-a] quinolines as adenosine A3 receptor ligands

Details for Australian Patent Application No. 2008259534 (hide)

Owner Sanofi-Aventis

Inventors Szlavik, Zoltan; Timari, Geza; Vargane Szeredi, Judit; Urban Szabo, Katalin; Szabo, Tibor; Susan, Edit; Mikus, Endre; Batori, Sandor; Kapui, Zoltan; Finet, Michel; Boer, Kinga

Agent Watermark

Pub. Number AU-B-2008259534

PCT Pub. Number WO2008/149168

Priority P0700395 07.06.07 HU

Filing date 2 June 2008

Wipo publication date 11 December 2008

Acceptance publication date 5 July 2012

International Classifications

C07D 215/58 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/4745

A61P 11/06 Drugs for disorders of the respiratory system

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07F 7/22 Compounds containing elements of the 4th Group of the Periodic System

Event Publications

7 January 2010 PCT application entered the National Phase

  PCT publication WO2008/149168 Priority application(s): WO2008/149168

5 July 2012 Application Accepted

  Published as AU-B-2008259534

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008259538-A planet carrier of planetary stage with a bogie plate

2008259526-Amorphous olmesartan medoxomil